TLRY
TLRY Tilray Brands Options Ahead of EarningsIf you haven`t bought TLRY here:
Then analyzing the options chain and the chart patterns of TLRY Tilray Brands prior to the earnings report this week,
I would consider purchasing the 2.50usd strike price Calls with
an expiration date of 2024-3-15,
for a premium of approximately $0.55.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
TLRY is it still a buy? SHORTTLRY dropped from a Head & Shoulders in the winter into the lows in June and July with a lot
of trading and accumulation as shown by the volume profile and its POC. Today TLRY
took off for a big gainer of a day. But why and
can it continue, The 5-minute chart shows plenty of volume support for today's move.
The 4H chart shows a scorching rise into the third standard deviation line above the mean VWAP
anchored into the earnings date two weeks ago which was a miss. Fundamentally, TLRY has
been buying shares of BUD and other beer brewing or distribution companies. If i were an
investor, I would be concerned. TLRY should focus on its core product and get good at
making cash and not burning it. While the MACD is still bullish and the mass index indicator not
yet triggering a reversal, I see a drop happening from the pop. Fundamentally TLRY
does not deserve the level of enthusiasm that it received. The EFT MJ had a big uptrend for the
day then printed a bearish engulfing candle on the close
as traders took their profits off the table.
In consideration of all of this, I think TLRY is a very safe short trade. I will zoom into the
5 minute time frame and go short from a high pivot. expecting a 10-15% return for the
remainder of the week as the flush or at least drop kicks in especially from inexperienced
traders buying in while TRLY is running high without reason into the greatly overbought zone.
I suppose it could pump from a short squeeze instead of leveling out and dropping, so
my trade will be small and risk constrained. Is you have any alternative idea why this
rose so much please let me know!
Can TLRY continue the momentum and is the news buyable ?TLRY jumped 10% in two trading days following the announcement of "gummie beer"" by
its subsidary Sweetwater Brewing. Traders who trade TLRY seem impressed and that is what
counts. Objectively, a gummie product containing alcohol seems to be a nonstarter given
regulatory hurtles and then marketing of familiarity. No doubt users could titrate the desired
effects as easily as liquid alcohol consumption. The chart of TLRY is not the best. Price
has surged to the overvalued zone of between 2 and 3 deviations above a mean VWAP anchored
last week. That is to say it may be overbought. The indicators are okay showing relative
strength in two-time frames over 50 but under 80 while the MACD K/D lines are rising and
parallel. I will add this to my watchlist for now. I am not yet ready to take a hit.
Potential breakout on TLRYYes, I know this stock is one of the most hated stocks in the universe, however technically this looks to be setting up for a strong move upward.
Weekly bullish divergence, Weekly spinning top candle from last week (sometimes a warning of a reversal), falling wedge structure with reducing volume, and double bottom area.
Could this setup fail?
ABSOLUTELY YES IT CAN FAIL!
So please be careful.
A break above 2.50 would be promising but weekly volume and candlesticks would have to confirm (see a stock like ATOM for what I'm talking about)
This could potentially run up into a safe banking vote and then sell on the vote news. Anyway, I like the potential setup, take it for what it's worth. See the ATOM analysis below for a similar setup
Tilray: Finally arrived 🧳Two weeks ago, Tilray took heart and jumped into the turquoise zone between $1.46 and $2.27, leaving a visible gap on its way. Near the bottom of this zone, the share could establish the low of wave II in white by now, meaning that soon, the bulls should take over. We expect Tilray to develop enough upwards momentum to leave the turquoise zone on the northern side via wave (1) in magenta, taking a first step in the direction of the resistance at $5.12.
TRLY Undervalued / Fed Fix Long SetupThe 2H chart on TLRY shows a volume profile showing the highest concentration of shares
traded at $2.65 or about 15% above the current price. Short sellers dominated there. Price has
descended down onto the support/demand zone. It is near to tow standard deviations below
the mean VWAP and so very undervalued.
Federal legislation intended to remedy the cannabis industry's issues with banking, commercial
loans and other financial liquidity has begun. This is huge for this subsector and could cause a
breakout from the deep undervalued territory.
I will take a long setup here for a decent amount of shares and hedge with a single
put option for risk management/insurance. ACB is similarly positioned.
Tilray: Wait and See… 😌After initially spurring the downwards movement so commendably from the high of wave (4) in magenta, Tilray has been relaxing in a sidewards movement since December. However, there is yet some work to be done! We expect the share to drop a bit deeper still to finish wave II in gray, whose low should then form the basis for a fresh upwards movement. Wave (1) in magenta should carry the course above the resistance at $5.12 eventually and even the subsequent counter movement should peter out above this mark.
TLRY Tilray Brands One of My TOP Stock Picks for 2023TLRY Tilray Brands is close to the pandemic low on a huge Falling Wedge and a Double Bottom Chart Pattern.
Looking at the TLRY Tilray Brands options chain, I would buy the $3 strike price Calls with
2023-1-20 expiration date for about
$0.16 premium.
TLRY Tilray Brands is One of My TOP Stock Picks for 2023!
Looking forward to read your opinion about it.
TLRY LongThe Play
TLRY has had a 30%+ pullback from the recent highs stemming from the December 2, 2022, recent legislation that was signed by President Biden. The strategy is to take advantage of a likely 10-15% rally in the short term.
Legislation: Highlights
After unanimous consent from the Senate, President Biden signed into law the Medical Marijuana and Cannabidiol Research Expansion Act, an act aimed at providing federal support to facilitate research of cannabis and its potential health benefits.
Legislation: Who’s Impacted
The medical community, including researchers in the bio-medical field, and those interested in the pharmaceutical applications of cannabis, as well as patients in need of more treatment options. The research will also help inform lawmakers, cannabis businesses, and consumers.
Things to look out for
The S&P500, or the general market, is in an overall bearish trend and showing signs of resistance after a recent 2-month bull rally.
About the company
Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia, and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK.
POTS- Bullish Momentum on Biden Pardons LONGWith a news catalyst, of the pardoning of all cannabis possession federal convictions,
POTS put in some wide range green candles to celebrate the increasing sediment towards
federal legalization.
As the 15-minute chart shows, a downtrending line was broken by price and then retested.
The setup is ripe for a swing long at this time. I see the constituents of this ETF
like SNDL CGC ACB TLRY IIPR as candidates for trades as well. On the other hand,
They could pop and drop and so be candidates to short or take put options.
TLRY Short | LT entry target $2.08NASDAQ:TLRY
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray , Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
TLRY Earnings are expected to be released on the 6th of October.
A break below $3.08 could potential lead to an ATL of $2.08
Tilray at support? Tilray
Short Term
We look to Buy at 3.18 (stop at 2.94)
We look to buy dips. There is scope for mild selling at the open but losses should be limited. A higher correction is expected. Expect trading to remain mixed and volatile. Previous support located at 3.120.
Our profit targets will be 3.74 and 3.99
Resistance: 3.75 / 4.00 / 5.15
Support: 3.20 / 3.00 / 2.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
POTX a cannabis ETF is a siwng LONG Setup ( ACB MJ TLRY)POTX as shown on the 30 minute chart
is showing an ascending megaphone pattern,
a reflection of increased volatility,
The price is sitting on the lower megaphone support line
and the RSI shows weakness.
Green up arrows show each time the price has touched the
support line it has reversed to the upside. The same for the RSI.
I see this an an excellent swing long setup with a target
of about $22 or 25% in a diversified EFT allowing for
a bit of risk mitigation.
MJ POTX CGC TRLY ACB SNDL IIPR Composite Index Update LONG This is an update of a previous recent idea. The MJ composite has had
a pullback and shows bullish RSI divergence. It is at support and has
various resistances dynamic and stationary above. The time is now
to analyse the preferred symbols / stocks within the composite.
( Alcohol thrived during the Great Depression, no reason not to assume
that cannabis will not thrive in the upcoming Great Depression V2).
A clear pullback scenario for the cannabis industrySeeing the growth and innovation that has occurred in recent months shows that the big wave is incoming. This formation clearly refers to pull back and bottom. Even one of the most conservative countries of Europe; Poland has given the Market Authorization to Tilray, Inc. (TLRY). Also, the election vibe has been taking charge of global media, federal legalization would be the starting point of new stoned FOMO.
Cannabis / MJ Stocks Reversal NotedToday a bunch of cannabis stocks showed up on my screener with
some good price action and high relative volume.
I set up a composite chart using some of the more heavily traded
stocks but no OTCs as well as a couple of the ETFs and the
REIT IIPR which manages and leases indoor cultivation farms.
While I found the composite price had been drifting downward
over preceding months, it bottomed on August 1 and has
rose 30% since then. Fundamentally this is a growth
industry with or without an impending recession.
The volume indicator shows rapidly rising volume
in the past two weeks, a good support for price action
I conclude the cannabis stocks may be candidates for
swing trades presently and into upcoming weeks.